Related Experiment Video
Updated: Jun 23, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Influence of left bundle branch block on long-term mortality in a population with heart failure
Fariborz Tabrizi1, Anders Englund, Mårten Rosenqvist
1Department of Cardiology, Karolinska University Hospital, Karolinska Institutet, S-141 86 Stockholm, Sweden. fariborz.tabrizi@karolinska.se
Insights
Left bundle branch block (LBBB) is common in heart failure (HF) patients and linked to high mortality. However, LBBB itself does not independently increase long-term mortality; comorbidities and heart dysfunction are the primary drivers.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Left bundle branch block (LBBB) is frequently observed in patients with symptomatic heart failure (HF).
- The independent prognostic value of LBBB in HF patients requiring hospitalization remains a subject of investigation.
- Understanding the specific contribution of LBBB to mortality is crucial for risk stratification and management.
Purpose of the Study:
- To determine the independent impact of LBBB on long-term mortality in a large cohort of symptomatic HF patients.
- To differentiate the effect of LBBB from confounding factors like comorbidities and myocardial function.
Main Methods:
- Prospective cohort study of 21,685 symptomatic HF admissions from the Swedish Heart Intensive care Admissions Register (1995-2003).
- Logistic regression analysis was used to evaluate long-term mortality, adjusting for multiple covariates.
- Subgroup analyses were performed, including and excluding left ventricular ejection fraction.
Main Results:
- LBBB was present in 20% of HF admissions and associated with a higher prevalence of cardiac comorbidities.
- Unadjusted analyses showed higher 1-, 5-, and 10-year mortality in HF patients with LBBB.
- After adjusting for comorbidities, LBBB was linked to increased 5-year mortality (OR, 1.21).
- However, when left ventricular ejection fraction was included, LBBB lost its independent association with 5-year mortality (OR, 0.99).
Conclusions:
- LBBB is prevalent in hospitalized HF patients and associated with high mortality.
- The increased long-term mortality in HF patients with LBBB appears primarily driven by underlying cardiac comorbidities and myocardial dysfunction, not LBBB itself.
- LBBB may serve as a marker for more severe cardiac disease rather than an independent predictor of mortality.
Background:
The purpose of this study was to assess the independent contribution of left bundle branch block (LBBB) on long-term mortality in a large cohort with symptomatic heart failure (HF) requiring hospitalization.
Methods And Results:
We studied a prospective cohort of 21 685 cases of symptomatic HF requiring hospitalization in the Register of Information and Knowledge about Swedish Heart Intensive care Admissions in 1995-2003. Long-term mortality was evaluated by Logistic regression analysis, adjusted for multiple covariates that could influence long-term prognosis. LBBB was present in 20% (4395 of 21 685) of HF admissions. Patients with LBBB had a higher prevalence of cardiac comorbid conditions than patients with no LBBB. 1-, 5-, and 10-year mortality was 31.5 vs. 28.4%, 69.3 vs. 61.3%, and 90.1 vs. 84.7% for HF patients with and without respectively LBBB. When adjusting for comorbidity, LBBB was associated with increased 5-year mortality (OR, 1.21; 95% CI, 1.10-1.35; P < 0.001). When left ventricular ejection fraction was included in the analysis LBBB had no longer any independent influence on 5-mortality (OR, 0.99; 95% CI, 0.62-1.56; P = 0.953).
Conclusion:
LBBB occurs in 1/5 in HF patients requiring hospitalization and is associated with a very high mortality. However, the high long-term mortality appears to be caused by cardiac comorbidities and myocardial dysfunction rather than the LBBB per se.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology

